Human epididymis secretory protein 4 in idiopathic inflammatory myopathy-associated interstitial lung disease
Clinical Rheumatology · 2025
DOI: 10.1007/s10067-025-07391-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Rheumatology, 2025. Verfasst von Liubing Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510080, China. Hauptthemen laut MEDLINE: Lung Diseases, Interstitial, Myositis, Proteins. Die Arbeit nennt 42 Literaturangaben. Gefördert von: Guangdong Basic and Applied Basic Research Fund, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
OBJECTIVE: The current study assessed the level of serum HE4 in patients with IIM to evaluate its feasibility in diagnosing IIM-ILD, as well as determined the association between HE4 and demographic, clinical, and laboratory characteristics of IIM patients. METHODS: Sera and clinical data were collected from 139 patients with IIMs and 135 healthy controls. We compared the clinical parameters between the high and low HE4 groups, and the relationship between HE4 levels and clinical parameters was determined. Moreover, the expression of HE4 in the lung tissue was accessed. RESULTS: HE4 level was significantly higher in the serum of IIM patients than in the controls (median 69.3 versus 33.5 μg/L, P < 0.001). Patients in the high HE4 group had higher ferritin (median 559 versus 83.7 μg/L, P = 0.006), frequencies of ILD(94.4% versus 56.1%, P < 0.001) and anti-Jo-1 autoantibodies (25.5% versus 5.7%, P = 0.018) compared with the low HE4 group. The immunohistochemical staining of HE4 in lung tissues was positive in IIM-ILD and negative in controls. CONCLUSION: Our findings suggested that serum HE4 might be a clinically useful biomarker for IIM-ILD. Key Points • Patients with IIMs, particularly those with IIM-ILD, had high serum levels of HE4. • Patients with high HE4 levels demonstrated a high prevalence of anti-Jo-1 autoantibodies. • Patients with IIM-ILD showed significant expression of HE4 within the lung tissue.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510080, China.
- Department of Laboratory Medicine, Nansha Division of the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 511466, China.
- Department of Pathology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510080, China.
- Department of Laboratory Medicine, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510080, China. tougao_fahsysu@163.com.
Förderung
- Guangdong Basic and Applied Basic Research Fund
- China Postdoctoral Science Foundation
Zitieren
APA
Li, L., Li, R., Zhu, H., Xu, H., Tan, H., Xu, H., Liu, M., Wang, F., Li, L., Shi, Q., & Liang, J. (2025). Human epididymis secretory protein 4 in idiopathic inflammatory myopathy-associated interstitial lung disease. Clinical Rheumatology. https://doi.org/10.1007/s10067-025-07391-2
Vancouver
Li L, Li R, Zhu H, Xu H, Tan H, Xu H, et al. Human epididymis secretory protein 4 in idiopathic inflammatory myopathy-associated interstitial lung disease. Clinical Rheumatology. 2025. doi:10.1007/s10067-025-07391-2
BibTeX
@article{Li2025,
author = {Li, Liubing and Li, Runzhao and Zhu, Hongji and Xu, Huiya and Tan, Hongxia and Xu, Hongxu and Liu, Min and Wang, Fen and Li, Laisheng and Shi, Qiong and Liang, Jianbo},
title = {Human epididymis secretory protein 4 in idiopathic inflammatory myopathy-associated interstitial lung disease},
journal = {Clinical Rheumatology},
year = {2025},
doi = {10.1007/s10067-025-07391-2}
}
EUVIMED